Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease.
Wolfe R, Wetmore JB, Woods RL, McNeil JJ, Gallagher H, Roderick P, Walker R, Nelson MR, Reid CM, Shah RC, Ernst ME, Lockery JE, Tonkin AM, Abhayaratna WP, Gibbs P, Wood EM, Mahady SE, Williamson JD, Donnan GA, Cloud GC, Murray AM, Polkinghorne KR.
Wolfe R, et al. Among authors: reid cm.
Kidney Int. 2021 Feb;99(2):466-474. doi: 10.1016/j.kint.2020.08.011. Epub 2020 Sep 10.
Kidney Int. 2021.
PMID: 32920022
Free PMC article.
Clinical Trial.